Effect of gender on the prognostic value of dobutamine stress myocardial contrast echocardiography
| Autor: | Eleutherios Tsiamis, A Verveniotis, Erifili Venieri, Constantina Aggeli, Dimitrios Varvarousis, Ioannis Felekos, Kostantinos Toutouzas, K Zisimos, Dimitrios Tousoulis, Kali Polytarchou |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty lcsh:Diseases of the circulatory (Cardiovascular) system medicine.medical_treatment Context (language use) Coronary Artery Disease 030204 cardiovascular system & hematology Revascularization Coronary artery disease 03 medical and health sciences Sex Factors 0302 clinical medicine Predictive Value of Tests Risk Factors Dobutamine Internal medicine Myocardial Revascularization medicine Stress Echocardiography Humans Mass Screening 030212 general & internal medicine Survival analysis Aged Retrospective Studies business.industry Myocardium Stroke Volume Dobutamine stress Middle Aged Prognosis medicine.disease Survival Analysis Death Hospitalization Myocardial contrast echocardiography Echocardiography lcsh:RC666-701 Cardiology Female Cardiology and Cardiovascular Medicine business Mace Echocardiography Stress Follow-Up Studies |
| Zdroj: | Hellenic Journal of Cardiology, Vol 58, Iss 6, Pp 419-424 (2017) |
| ISSN: | 1109-9666 |
| Popis: | Background: Dobutamine stress contrast echo (DSCE) has a well-established prognostic value in the context of coronary artery disease (CAD). However, data regarding its prognostic capability separately in men and women are scarce. The aim of the current study was to assess gender-related differences in the prognostic performance of DSCE. Methods: DSCE was performed in 2645 consecutive patients, who were classified into two groups depending on gender. Follow-up lasted 57.1±10.1 months. End points included all-cause mortality, cardiac death, late revascularization, and hospitalizations. Survival analysis was performed comparing men and women. Results: Of the 2645 patients (59.3±8.7 years), 69.1% were men. DSCE was positive in 23.4% of male patients, while in females, the respective percentage was 14.3%. There was statistically significant difference between the two groups with regard to end point occurrence (11.6% vs. 6.1%, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|